https://www.selleckchem.com/pr....oducts/alpha-naphtho
, with these declines significantly greater at 7 weeks than 3 weeks after commencing CRT. Conclusions Patients with HNC undergoing 7 weeks of CRT showed clinically significant increases in the incidence of probable sarcopenia based on their total SARC-F score as well as clinically significant declines in handgrip strength, skeletal muscle mass and Timed Up and Go performance. Due to the relationship between sarcopenia and a host of adverse events related to CRT in HNC patients, these results suggest that oncologists and the
Like
Comment
Share
